ChemoCentryx
- World
VFMCRP and ChemoCentryx Provide Topline Results From ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)
St. Gallen, Switzerland & Mountain View, Calif., United States: As in ANCA vasculitis, avacopan demonstrated statistically significant improvement in renal…
Read More » - United States
VFMCRP and ChemoCentryx announce European Medicines Agency has accepted to review the Marketing Authorization Application for avacopan
St. Gallen, Switzerland & Mountain View, Calif., United States: Companies have completed the EU regulatory application for marketing approval of…
Read More »